205 related articles for article (PubMed ID: 30700487)
1. School-based educational and on-site vaccination intervention among adolescents: study protocol of a cluster randomised controlled trial.
Gellert P; Bethke N; Seybold J
BMJ Open; 2019 Jan; 9(1):e025113. PubMed ID: 30700487
[TBL] [Abstract][Full Text] [Related]
2. A school-based educational on-site vaccination intervention for adolescents in an urban area in Germany: feasibility and psychometric properties of instruments in a pilot study.
Bethke N; Gellert P; Knoll N; Weber N; Seybold J
BMC Public Health; 2022 Jan; 22(1):60. PubMed ID: 35012511
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children: A 5-year follow-up of a randomised controlled study.
John T; Voysey M; Yu LM; McCarthy N; Baudin M; Richard P; Fiquet A; Kitchin N; Pollard AJ
Vaccine; 2015 Aug; 33(36):4579-85. PubMed ID: 26165918
[TBL] [Abstract][Full Text] [Related]
4. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
5. Increasing vaccinations through an on-site school-based education and vaccination program: A city-wide cluster randomized controlled trial.
Bethke N; O'Sullivan JL; Keller J; von Bernuth H; Gellert P; Seybold J
Appl Psychol Health Well Being; 2024 Feb; ():. PubMed ID: 38299711
[TBL] [Abstract][Full Text] [Related]
6. An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children.
Klein NP; Weston WM; Kuriyakose S; Kolhe D; Howe B; Friedland LR; Van Der Meeren O
Vaccine; 2012 Jan; 30(3):668-74. PubMed ID: 22064267
[TBL] [Abstract][Full Text] [Related]
7. HPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescents.
Skinner SR; Davies C; Cooper S; Stoney T; Marshall H; Jones J; Collins J; Hutton H; Parrella A; Zimet G; Regan DG; Whyte P; Brotherton JM; Richmond P; McCaffrey K; Garland SM; Leask J; Kang M; Braunack-Mayer A; Kaldor J; McGeechan K
BMC Public Health; 2015 Sep; 15():896. PubMed ID: 26373926
[TBL] [Abstract][Full Text] [Related]
8. A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration.
MMR-158 Study Group
Hum Vaccin Immunother; 2019; 15(4):786-799. PubMed ID: 30785357
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years.
Black S; Friedland LR; Schuind A; Howe B;
Vaccine; 2006 Aug; 24(35-36):6163-71. PubMed ID: 16759769
[TBL] [Abstract][Full Text] [Related]
10. Effect of a School-Based Educational Intervention About the Human Papillomavirus Vaccine on Psychosocial Outcomes Among Adolescents: Analysis of Secondary Outcomes of a Cluster Randomized Trial.
Davies C; Marshall HS; Zimet G; McCaffery K; Brotherton JML; Kang M; Garland S; Kaldor J; McGeechan K; Skinner SR;
JAMA Netw Open; 2021 Nov; 4(11):e2129057. PubMed ID: 34726749
[TBL] [Abstract][Full Text] [Related]
11. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
Sricharoenchai S; Sirivichayakul C; Chokephaibulkit K; Pitisuttithum P; Dhitavat J; Pitisuthitham A; Phongsamart W; Boonnak K; Lapphra K; Sabmee Y; Wittawatmongkol O; Chinwangso P; Poredi IK; Petre J; Thai PH; Viviani S
Lancet Infect Dis; 2018 Jan; 18(1):58-67. PubMed ID: 29066131
[TBL] [Abstract][Full Text] [Related]
12. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.
Embree J; Law B; Voloshen T; Tomovici A
Clin Vaccine Immunol; 2015 Mar; 22(3):282-90. PubMed ID: 25540274
[TBL] [Abstract][Full Text] [Related]
14. Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands.
Tielemans SMAJ; de Melker HE; Hahné SJM; Boef AGC; van der Klis FRM; Sanders EAM; van der Sande MAB; Knol MJ
BMJ; 2017 Aug; 358():j3862. PubMed ID: 28855159
[No Abstract] [Full Text] [Related]
15. Chronically ill adolescents are also incompletely vaccinated: A cross-sectional study in France.
Gras-Le Guen C; Legrand A; Caquard M; Micaelli X; Picherot G; Lacroix S; Volteau C; Launay E
Vaccine; 2017 Aug; 35(36):4707-4712. PubMed ID: 28760611
[TBL] [Abstract][Full Text] [Related]
16. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections.
Sørup S; Benn CS; Poulsen A; Krause TG; Aaby P; Ravn H
JAMA; 2014 Feb; 311(8):826-35. PubMed ID: 24570246
[TBL] [Abstract][Full Text] [Related]
17. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial.
Zimmermann U; Gavazzi G; Richard P; Eymin C; Soubeyrand B; Baudin M
Vaccine; 2013 Mar; 31(11):1496-502. PubMed ID: 23313654
[TBL] [Abstract][Full Text] [Related]
19. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.
Stein-Zamir C; Israeli A
Hum Vaccin Immunother; 2017 Sep; 13(9):2102-2110. PubMed ID: 28696824
[TBL] [Abstract][Full Text] [Related]
20. A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial.
Scheifele DW; Halperin SA; Ochnio JJ; Ferguson AC; Skowronski DM
Pediatr Infect Dis J; 2005 Dec; 24(12):1059-66. PubMed ID: 16371866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
